EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF
Compounds of formula A, a method for using said compounds as an EGFR inhibitor, and a pharmaceutical composition comprising said compounds. The compounds can be used to treat, prevent or ameliorate diseases or conditions such as cancers or infections. L'invention concerne des composés de formul...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DING, Lieming WANG, Jiabing SONG, Xiaodong LIU, Xiangyong QIU, Changyong SHEN, Qichao |
| description | Compounds of formula A, a method for using said compounds as an EGFR inhibitor, and a pharmaceutical composition comprising said compounds. The compounds can be used to treat, prevent or ameliorate diseases or conditions such as cancers or infections.
L'invention concerne des composés de formule A, un procédé d'utilisation desdits composés en tant qu'inhibiteur de l'EGFR, et une composition pharmaceutique comprenant lesdits composés. Les composés peuvent être utilisés pour traiter, prévenir ou améliorer des maladies ou affections telles que des cancers ou des infections.
提供了式A化合物，使用这些化合物作为EGFR抑制剂的方法，以及包含这些化合物的药物组合物。该化合物可用于治疗、预防或改善诸如癌症或感染的疾病或病症。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022206797A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022206797A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022206797A13</originalsourceid><addsrcrecordid>eNrjZNB3dXcLUvD08_B08gzxD9JRcPRzUXD29w3wD_YM8fT3A_NDg10VQjxcg1z93XgYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkZGRgZm5pbmjoTFxqgCEFSa8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF</title><source>esp@cenet</source><creator>DING, Lieming ; WANG, Jiabing ; SONG, Xiaodong ; LIU, Xiangyong ; QIU, Changyong ; SHEN, Qichao</creator><creatorcontrib>DING, Lieming ; WANG, Jiabing ; SONG, Xiaodong ; LIU, Xiangyong ; QIU, Changyong ; SHEN, Qichao</creatorcontrib><description>Compounds of formula A, a method for using said compounds as an EGFR inhibitor, and a pharmaceutical composition comprising said compounds. The compounds can be used to treat, prevent or ameliorate diseases or conditions such as cancers or infections.
L'invention concerne des composés de formule A, un procédé d'utilisation desdits composés en tant qu'inhibiteur de l'EGFR, et une composition pharmaceutique comprenant lesdits composés. Les composés peuvent être utilisés pour traiter, prévenir ou améliorer des maladies ou affections telles que des cancers ou des infections.
提供了式A化合物，使用这些化合物作为EGFR抑制剂的方法，以及包含这些化合物的药物组合物。该化合物可用于治疗、预防或改善诸如癌症或感染的疾病或病症。 <img file="159725dest_path_image001.jpg" he="51.86" img-content="drawing" img-format="jpg" inline="yes" orientation="portrait" wi="129.91"/></description><language>chi ; eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221006&DB=EPODOC&CC=WO&NR=2022206797A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221006&DB=EPODOC&CC=WO&NR=2022206797A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DING, Lieming</creatorcontrib><creatorcontrib>WANG, Jiabing</creatorcontrib><creatorcontrib>SONG, Xiaodong</creatorcontrib><creatorcontrib>LIU, Xiangyong</creatorcontrib><creatorcontrib>QIU, Changyong</creatorcontrib><creatorcontrib>SHEN, Qichao</creatorcontrib><title>EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF</title><description>Compounds of formula A, a method for using said compounds as an EGFR inhibitor, and a pharmaceutical composition comprising said compounds. The compounds can be used to treat, prevent or ameliorate diseases or conditions such as cancers or infections.
L'invention concerne des composés de formule A, un procédé d'utilisation desdits composés en tant qu'inhibiteur de l'EGFR, et une composition pharmaceutique comprenant lesdits composés. Les composés peuvent être utilisés pour traiter, prévenir ou améliorer des maladies ou affections telles que des cancers ou des infections.
提供了式A化合物，使用这些化合物作为EGFR抑制剂的方法，以及包含这些化合物的药物组合物。该化合物可用于治疗、预防或改善诸如癌症或感染的疾病或病症。 <img file="159725dest_path_image001.jpg" he="51.86" img-content="drawing" img-format="jpg" inline="yes" orientation="portrait" wi="129.91"/></description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB3dXcLUvD08_B08gzxD9JRcPRzUXD29w3wD_YM8fT3A_NDg10VQjxcg1z93XgYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkZGRgZm5pbmjoTFxqgCEFSa8</recordid><startdate>20221006</startdate><enddate>20221006</enddate><creator>DING, Lieming</creator><creator>WANG, Jiabing</creator><creator>SONG, Xiaodong</creator><creator>LIU, Xiangyong</creator><creator>QIU, Changyong</creator><creator>SHEN, Qichao</creator><scope>EVB</scope></search><sort><creationdate>20221006</creationdate><title>EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF</title><author>DING, Lieming ; WANG, Jiabing ; SONG, Xiaodong ; LIU, Xiangyong ; QIU, Changyong ; SHEN, Qichao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022206797A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DING, Lieming</creatorcontrib><creatorcontrib>WANG, Jiabing</creatorcontrib><creatorcontrib>SONG, Xiaodong</creatorcontrib><creatorcontrib>LIU, Xiangyong</creatorcontrib><creatorcontrib>QIU, Changyong</creatorcontrib><creatorcontrib>SHEN, Qichao</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DING, Lieming</au><au>WANG, Jiabing</au><au>SONG, Xiaodong</au><au>LIU, Xiangyong</au><au>QIU, Changyong</au><au>SHEN, Qichao</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF</title><date>2022-10-06</date><risdate>2022</risdate><abstract>Compounds of formula A, a method for using said compounds as an EGFR inhibitor, and a pharmaceutical composition comprising said compounds. The compounds can be used to treat, prevent or ameliorate diseases or conditions such as cancers or infections.
L'invention concerne des composés de formule A, un procédé d'utilisation desdits composés en tant qu'inhibiteur de l'EGFR, et une composition pharmaceutique comprenant lesdits composés. Les composés peuvent être utilisés pour traiter, prévenir ou améliorer des maladies ou affections telles que des cancers ou des infections.
提供了式A化合物，使用这些化合物作为EGFR抑制剂的方法，以及包含这些化合物的药物组合物。该化合物可用于治疗、预防或改善诸如癌症或感染的疾病或病症。 <img file="159725dest_path_image001.jpg" he="51.86" img-content="drawing" img-format="jpg" inline="yes" orientation="portrait" wi="129.91"/></abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng ; fre |
| recordid | cdi_epo_espacenet_WO2022206797A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A36%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DING,%20Lieming&rft.date=2022-10-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022206797A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |